163 related articles for article (PubMed ID: 38731562)
21. Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds.
Istanbullu H; Bayraktar G; Akbaba H; Cavus I; Coban G; Debelec Butuner B; Kilimcioglu AA; Ozbilgin A; Alptuzun V; Erciyas E
Arch Pharm (Weinheim); 2020 Aug; 353(8):e1900325. PubMed ID: 32484266
[TBL] [Abstract][Full Text] [Related]
22. Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Szular J; Kaiser M
Eur J Med Chem; 2016 Jul; 117():179-86. PubMed ID: 27092415
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents--part III.
Ronga L; Del Favero M; Cohen A; Soum C; Le Pape P; Savrimoutou S; Pinaud N; Mullié C; Daulouede S; Vincendeau P; Farvacques N; Agnamey P; Pagniez F; Hutter S; Azas N; Sonnet P; Guillon J
Eur J Med Chem; 2014 Jun; 81():378-93. PubMed ID: 24858543
[TBL] [Abstract][Full Text] [Related]
24. 8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases.
Fersing C; Boudot C; Pedron J; Hutter S; Primas N; Castera-Ducros C; Bourgeade-Delmas S; Sournia-Saquet A; Moreau A; Cohen A; Stigliani JL; Pratviel G; Crozet MD; Wyllie S; Fairlamb A; Valentin A; Rathelot P; Azas N; Courtioux B; Verhaeghe P; Vanelle P
Eur J Med Chem; 2018 Sep; 157():115-126. PubMed ID: 30092366
[TBL] [Abstract][Full Text] [Related]
25. Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents.
Corfu AI; Santarem N; Luelmo S; Mazza G; Greco A; Altomare A; Ferrario G; Nasta G; Keminer O; Aldini G; Tamborini L; Basilico N; Parapini S; Gul S; Cordeiro-da-Silva A; Conti P; Borsari C
ACS Infect Dis; 2024 Jun; 10(6):2222-2238. PubMed ID: 38717116
[TBL] [Abstract][Full Text] [Related]
26. Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents.
Rashid U; Sultana R; Shaheen N; Hassan SF; Yaqoob F; Ahmad MJ; Iftikhar F; Sultana N; Asghar S; Yasinzai M; Ansari FL; Qureshi NA
Eur J Med Chem; 2016 Jun; 115():230-44. PubMed ID: 27017551
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of trypanosome alternative oxidase without its N-terminal mitochondrial targeting signal (ΔMTS-TAO) by cationic and non-cationic 4-hydroxybenzoate and 4-alkoxybenzaldehyde derivatives active against T. brucei and T. congolense.
Ebiloma GU; Ayuga TD; Balogun EO; Gil LA; Donachie A; Kaiser M; Herraiz T; Inaoka DK; Shiba T; Harada S; Kita K; de Koning HP; Dardonville C
Eur J Med Chem; 2018 Apr; 150():385-402. PubMed ID: 29544150
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and antitrypanosomal activity of heteroaryl-based 1,2,4-triazole and 1,3,4-oxadiazole derivatives.
Shaykoon MS; Marzouk AA; Soltan OM; Wanas AS; Radwan MM; Gouda AM; Youssif BGM; Abdel-Aziz M
Bioorg Chem; 2020 Jul; 100():103933. PubMed ID: 32446119
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of lupeol derivatives and their antileishmanial and antitrypanosomal activities.
Machado VR; Sandjo LP; Pinheiro GL; Moraes MH; Steindel M; Pizzolatti MG; Biavatti MW
Nat Prod Res; 2018 Feb; 32(3):275-281. PubMed ID: 28715940
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the
Shamshad H; Hafiz A; Althagafi II; Saeed M; Mirza AZ
Curr Comput Aided Drug Des; 2020; 16(5):583-598. PubMed ID: 31453790
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of Triclisia patens and some bisbenzylisoquinoline alkaloids against Leishmania donovani and Trypanosoma brucei brucei.
del Rayo Camacho M; Phillipson JD; Croft SL; Rock P; Marshall SJ; Schiff PL
Phytother Res; 2002 Aug; 16(5):432-6. PubMed ID: 12203262
[TBL] [Abstract][Full Text] [Related]
32. Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity.
Di Pisa F; Landi G; Dello Iacono L; Pozzi C; Borsari C; Ferrari S; Santucci M; Santarem N; Cordeiro-da-Silva A; Moraes CB; Alcantara LM; Fontana V; Freitas-Junior LH; Gul S; Kuzikov M; Behrens B; Pöhner I; Wade RC; Costi MP; Mangani S
Molecules; 2017 Mar; 22(3):. PubMed ID: 28282886
[TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of N-(3-sulfamoylphenyl)amides as Trypanosoma brucei leucyl-tRNA synthetase inhibitors.
Li Z; Xin W; Wang Q; Zhu M; Zhou H
Eur J Med Chem; 2021 May; 217():113319. PubMed ID: 33725631
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and in vitro antiprotozoal activities of 5-phenyliminobenzo[a]phenoxazine derivatives.
Shi XL; Ge JF; Liu BQ; Kaiser M; Wittlin S; Brun R; Ihara M
Bioorg Med Chem Lett; 2011 Oct; 21(19):5804-7. PubMed ID: 21868222
[TBL] [Abstract][Full Text] [Related]
35. Novel alkylpolyaminoguanidines and alkylpolyaminobiguanides with potent antitrypanosomal activity.
Bi X; Lopez C; Bacchi CJ; Rattendi D; Woster PM
Bioorg Med Chem Lett; 2006 Jun; 16(12):3229-32. PubMed ID: 16616495
[TBL] [Abstract][Full Text] [Related]
36. Lipophilic conformationally constrained spiro carbocyclic 2,6-diketopiperazine-1-acetohydroxamic acid analogues as trypanocidal and leishmanicidal agents: An extended SAR study.
Zoidis G; Tsotinis A; Tsatsaroni A; Taylor MC; Kelly JM; Efstathiou A; Smirlis D; Fytas G
Chem Biol Drug Des; 2018 Feb; 91(2):408-421. PubMed ID: 28834291
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antikinetoplastid activities of 3-substituted quinolinones derivatives.
Audisio D; Messaoudi S; Cojean S; Peyrat JF; Brion JD; Bories C; Huteau F; Loiseau PM; Alami M
Eur J Med Chem; 2012 Jun; 52():44-50. PubMed ID: 22472166
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro antitrypanosomal evaluation of novel 6-heteroarylidene-substituted quinolone derivatives.
Angula KT; Legoabe LJ; Swart T; Hoppe HC; Beteck RM
Eur J Med Chem; 2022 Jan; 227():113913. PubMed ID: 34656043
[TBL] [Abstract][Full Text] [Related]
39. Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity.
Uliassi E; Fiorani G; Krauth-Siegel RL; Bergamini C; Fato R; Bianchini G; Carlos Menéndez J; Molina MT; López-Montero E; Falchi F; Cavalli A; Gul S; Kuzikov M; Ellinger B; Witt G; Moraes CB; Freitas-Junior LH; Borsari C; Costi MP; Bolognesi ML
Eur J Med Chem; 2017 Dec; 141():138-148. PubMed ID: 29031061
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.
Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B
Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
